Status:
UNKNOWN
Clinical Study of LBBP
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Bradyarrhythmias
Heart Failure
Eligibility:
All Genders
18-100 years
Brief Summary
At present, cardiac pacing has been widely used in the treatment of bradyarrhythmias and heart failure, which can effectively improve the survival rate of patients. With the rapid development of techn...
Eligibility Criteria
Inclusion
- Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
- Patients who have the ability to understand the test and can cooperate with investigators.
Exclusion
- Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT04919447
Start Date
June 1 2021
End Date
August 1 2025
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiaohong Pan
Hangzhou, Zhejiang, China, 310000